HS

Hema Singh

Director Director DIN 03430778
DIN 03430778 First appointment Feb 2011 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2011
Shareholding value •••• Premium profile

About Hema Singh

Data last updated:

Hema Singh was a Director at Kansdee Pharmaceuticals Private Limited (2011–2015) and Director at Kansdee Ventures Private Limited (2012–2015). The companies operate in Healthcare and Infrastructure and Utilities.

DIN 03430778
Primary Designation Director
Industry Healthcare
First Appointment 25 Feb 2011

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Feb 20112011Strike Off
Kansdee Ventures Private Limited U72900DL2012PTC240153
Director13 Aug 20122012₹1.62 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Kansdee Pharmaceuticals Private Limited
Kansdee Ventures Private Limited
Premium access

Shareholding and investment profile for Hema Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hema Singh

Hema Singh was first appointed on 25 Feb 2011 as Director at Kansdee Pharmaceuticals Private Limited. The most recent appointment on record is 13 Aug 2012 at Kansdee Ventures Private Limited.

Hema Singh held 2 earlier board appointments: Kansdee Pharmaceuticals Private Limited (Director, 25 Feb 2011 to 05 Jan 2015); Kansdee Ventures Private Limited (Director, 13 Aug 2012 to 03 Jan 2015).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available